alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>               DEC-31-1999
<PERIOD-END>                    JUN-30-1999

<CASH>                          990
<SECURITIES>                      0
<RECEIVABLES>                84,739
<ALLOWANCES>                  4,523
<INVENTORY>                       0
<CURRENT-ASSETS>                  0
<PP&E>                        5,558
<DEPRECIATION>                2,673
<TOTAL-ASSETS>               85,553
<CURRENT-LIABILITIES>             0
<BONDS>                      71,207
<PREFERRED-MANDATORY>             0
<PREFERRED>                      10
<COMMON>                         38
<OTHER-SE>                   10,450
<TOTAL-LIABILITY-AND-EQUITY> 85,553
<SALES>                           0
<TOTAL-REVENUES>             17,566
<CGS>                             0
<TOTAL-COSTS>                     0
<OTHER-EXPENSES>             12,733
<LOSS-PROVISION>              1,851
<INTEREST-EXPENSE>            3,285
<INCOME-PRETAX>                (223)
<INCOME-TAX>                   (130)
<INCOME-CONTINUING>             (93)
<DISCONTINUED>                    0
<EXTRAORDINARY>                   0
<CHANGES>                         0
<NET-INCOME>                    (93)
<EPS-BASIC>                  (.12)
<EPS-DILUTED>                  (.12)


</TABLE>
# C_2021096EN.01000301.xml

| 22.3.2021 | EN | Official Journal of the European Union | C 96/3 |
| --- | --- | --- | --- |

22.3.2021

EN

Official Journal of the European Union

C 96/3

---

Non-opposition to a notified concentration

(Case M.10166 — Latour Capital/Watling Street Capital Partners/Funecap Groupe)

(Text with EEA relevance)

(2021/C 96/03)

On 11 March 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes. |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes.

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10166. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10166. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
EXHIBIT 10.2




November 12, 1996



Mr. Andrew Campbell
13 Dan St. Graceville
Qld. Australia  4075

Dear Andrew:

On behalf  of  Saville  Systems  Canada,  Ltd.,  I am  pleased  to offer you the
position of Senior Vice President, Research and Development.

This  position  will be based in Edmonton and is offered with the  understanding
that you will commence employment on or before January 2, 1997. Your base salary
will be $145,000  (US),  with a year end bonus based on a combination of company
performance and personal performance up to 30% of your base salary. The benefits
plan  will be the  traditional  Saville  Systems  benefits  as  outlined  in the
attached summary. In addition,  you will have three weeks vacation. As a signing
bonus, you will receive 50,000 stock options.  The exercise price of the options
will be the closing market price on the date you commence employment.

With this offer, the following conditions apply:

1.    Acceptance of this offer within 5 days be returning a signed copy of this 
      letter.
2.    You agree to sign the attached Invention and Non-Disclosure Agreement.

Andrew,  I look forward to hearing from you soon and  welcoming  you aboard Team
Saville.

Sincerely,

/s/Lorraine M. Kruper for:                              /s/Andrew Campbell
                                                        Signature of Acceptance

John J. Boyle III                                       December 26, 1996   
President and Chief Executive Officer                   Date
Skip to main content

Privacy Policy•Site map

# Omnibus Autism Proceeding

**Vaccine Program/Office of Special MastersOmnibus Autism Proceeding**

Guidance to petitioners on how to exit the vaccine program

View the Docket of Omnibus Autism Proceeding.

Autism Test Case Decisions and Background Information

Howard T. Markey National Courts Building • 717 Madison Place, NW, Washington, DC 20439 • 202-357-6400
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET STATEMENT OF OPERATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH 1ST QUARTER 10-Q.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                         133,117
<SECURITIES>                                         0
<RECEIVABLES>                                   47,589
<ALLOWANCES>                                    26,960
<INVENTORY>                                     28,271
<CURRENT-ASSETS>                               182,017
<PP&E>                                         838,906
<DEPRECIATION>                                  29,739
<TOTAL-ASSETS>                                 991,184
<CURRENT-LIABILITIES>                          454,762
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,659,620
<OTHER-SE>                                 (1,123,198)
<TOTAL-LIABILITY-AND-EQUITY>                   991,184
<SALES>                                         30,678
<TOTAL-REVENUES>                                30,678
<CGS>                                           17,199
<TOTAL-COSTS>                                   17,199
<OTHER-EXPENSES>                               239,420
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (225,941)
<EPS-PRIMARY>                                    (.03)
<EPS-DILUTED>                                    (.03)
        

</TABLE>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 235 Referred in Senate (RFS)]

114th CONGRESS
  1st Session
                                H. R. 235

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 10, 2015

     Received; read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 AN ACT

 
          To permanently extend the Internet Tax Freedom Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Permanent Internet Tax Freedom 
Act''.

SEC. 2. PERMANENT MORATORIUM ON INTERNET ACCESS TAXES AND MULTIPLE AND 
              DISCRIMINATORY TAXES ON ELECTRONIC COMMERCE.

    (a) In General.--Section 1101(a) of the Internet Tax Freedom Act 
(47 U.S.C. 151 note) is amended by striking ``during the period 
beginning November 1, 2003, and ending October 1, 2015''.
    (b) Effective Date.--The amendment made by this section shall apply 
to taxes imposed after the date of the enactment of this Act.

            Passed the House of Representatives June 9, 2015.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
#### HALLING, Respondent, v. NASSAU ELECTRIC R. CO., Appellant.

(Supreme Court, Appellate Division, Second Department.

January 12, 1897.)

Action by Matilda Hailing, as administratrix, against the Nassau Electric Railroad Company.

No opinion. Judgment and order unanimously affirmed, with costs.
Rita Morris McKeeman, 

Plaintiff, 

v. 

United States, 

Defendant. 

UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

Civil Action No. 

MEMORANDUM OPINION 

FILED 

AUG 20 20m 

Clerk, U.S. District 3. Bankruptcy 

Courts for the District of Columbia 

10 1412 

This matter is before the Court on its initial review of plaintiffs pro se complaint and 

application for leave to proceed informa pauperis. The Court will grant the in forma pauperis 

application and dismiss the case because the complaint fails to meet the minimal pleading 

requirements of Rule 8(a) ofthe Federal Rules of Civil Procedure. 

Pro se litigants must comply with the Federal Rules of Civil Procedure. Jarrell v. Tisch, 

656 F. Supp. 237,239 (D.D.C. 1987). Rule 8(a) of the Federal Rules of Civil Procedure requires 

complaints to contain "( 1) a short and plain statement of the grounds for the court's jurisdiction 

[and] (2) a short and plain statement of the claim showing that the pleader is entitled to relief." 

Fed. R. Civ. P. 8(a); see Ashcroft v. Iqbal, 129 S.Ct. 1937, 1950 (2009); Ciralsky v. CIA, 355 

F.3d 661, 668-71 (D.C. Cir. 2004). The Rule 8 standard ensures that defendants receive fair 

notice of the claim being asserted so that they can prepare a responsive answer and an adequate 

defense and determine whether the doctrine of res judicata applies. Brown v. Califano, 75 

F.R.D. 497,498 (D.D.C. 1977). 
Plaintiff is a District of Columbia resident suing the United States. The complaint, 

consisting mostly of disjointed phrases, fails to provide any notice of a claim. A separate Order 

of dismissal accompanies this Memorandum Opinion. 

Date: August fL, 2010 

2
Exhibit 31



CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

SEC RELEASE NO. 33-8124



I, Marc Hazout, President and Chief Executive Officer of the Company, certify that:

(1) I have reviewed this annual report on Form 10-KSB of American Entertainment and Animation Corp.;

(2) Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

(3) Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

(a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the "Evaluation Date"); and

(c) Presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

(5) I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and

(6) I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

|Dated: April 14, 2004 | /s/ Marc Hazout                                   
|--------------------- | --------------------------------------------------
|                      | Marc Hazout, President and Chief Executive Officer
# C_2021482EN.01001701.xml

| 30.11.2021 | EN | Official Journal of the European Union | C 482/17 |
| --- | --- | --- | --- |

30.11.2021

EN

Official Journal of the European Union

C 482/17

---

Prior notification of a concentration

(Case M.10557 – CPP INVESTSMENTS / VOTORANTIM / VOTENER)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 482/06)

1.

This notification concerns the following undertakings:

| — | CPP Investments (Canada), |
| --- | --- |

—

CPP Investments (Canada),

| — | Votorantim S.A. (‘Votorantim’, Brazil), |
| --- | --- |

—

Votorantim S.A. (‘Votorantim’, Brazil),

| — | Votener – Votorantim Comercializadora de Energia Ltda. (‘Votener’, Brazil), a subsidiary of Votorantim Geração de Energia S.A. (‘VGE’, Brazil), currently a subsidiary of Votorantim. |
| --- | --- |

—

Votener – Votorantim Comercializadora de Energia Ltda. (‘Votener’, Brazil), a subsidiary of Votorantim Geração de Energia S.A. (‘VGE’, Brazil), currently a subsidiary of Votorantim.

CPP Investments and Votorantim acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Votener. The concentration is accomplished by way of purchase of shares.

2.

| — | for CPP Investments: an investment management organisation that invests the funds of the Canada Pension Plan Fund, |
| --- | --- |

—

for CPP Investments: an investment management organisation that invests the funds of the Canada Pension Plan Fund,

| — | for Votorantim: active in a variety of business segments, including cement and concrete, mining and metallurgy, concentrated orange juice, chemical specialty markets, electric power generation and financial sector, |
| --- | --- |

—

for Votorantim: active in a variety of business segments, including cement and concrete, mining and metallurgy, concentrated orange juice, chemical specialty markets, electric power generation and financial sector,

| — | for Votener: the wholesale trade of electric energy in Brazil. |
| --- | --- |

—

for Votener: the wholesale trade of electric energy in Brazil.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10557 – CPP INVESTSMENTS / VOTORANTIM / VOTENER

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---
I 

114TH CONGRESS 

1ST SESSION H. R. 2264 

To amend title 10, United States Code, to establish a space-available transportation priority for veterans of the Armed Forces who have a serviceconnected, permanent disability rated as total. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 12, 2015 

Mr. BILIRAKIS introduced the following bill; which was referred to the 

Committee on Armed Services 

A BILL 

To amend title 10, United States Code, to establish a spaceavailable transportation priority for veterans of the 

Armed Forces who have a service-connected, permanent 

disability rated as total. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. TRANSPORTATION ON MILITARY AIRCRAFT ON 

4 A SPACE-AVAILABLE BASIS FOR DISABLED 

5 VETERANS WITH A SERVICE-CONNECTED, 

6 PERMANENT DISABILITY RATED AS TOTAL. 

7 (a) AVAILABILITY OF TRANSPORTATION.—Section 

8 2641b of title 10, United States Code, is amended— 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•HR 2264 IH

1 (1) by redesignating subsection (f) as sub2 section (g); and 

3 (2) by inserting after subsection (e) the fol4 lowing new subsection (f): 

5 ‘‘(f) SPECIAL PRIORITY FOR CERTAIN DISABLED

6 VETERANS.—(1) The Secretary of Defense shall provide 

7 transportation on scheduled and unscheduled military 

8 flights within the continental United States and on sched9 uled overseas flights operated by the Air Mobility Com10 mand on a space-available basis for any veteran with a 

11 service-connected, permanent disability rated as total on 

12 the same basis as such transportation is provided to mem13 bers of the armed forces entitled to retired or retainer pay. 

14 ‘‘(2) The transportation priority required by para15 graph (1) for veterans described in such paragraph applies 

16 whether or not the Secretary establishes the travel pro17 gram authorized by this section. 

18 ‘‘(3) In this subsection, the terms ‘veteran’ and ‘serv19 ice-connected’ have the meanings given those terms in sec20 tion 101 of title 38.’’. 

21 (b) EFFECTIVE DATE.—Subsection (f) of section 

22 2641b of title 10, United States Code, as added by sub23 section (a), shall take effect at the end of the 90-day pe24 riod beginning on the date of the enactment of this Act. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS
----

CERTIFICATION 

I, Kirk Boyd, certify that: 

1.     I have reviewed this report on Form 10-KSB/A; 

2.     Based on my knowledge, this annual report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this annualreport; 

3.     Based on my knowledge, the financial statements, and other financialinformation included in this annual report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this annual report; 4. Theregistrant's other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15 (e) and 15d-15(e)) for the registrant and we have: 

(a)    designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this annual report is being prepared;

(b)    evaluated the effectiveness of the registrant's disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and 

(c)    disclosed inthis report any change in the registrant's internal control over financialreporting that occurred during the registrant's most recent fiscal quarter (theregistration's fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant's internal control over financial reporting; and 

5.     Theregistrant's other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theregistrant's auditors and the audit committee of registrant's board of directors(or persons performing the equivalent function): 

(a)    all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant's ability to record, process,summarize and report financial information; and 

(b)    any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant's internal controls overfinancial reporting. 

Date: July 9, 2007 

/s/ Kirk Boyd                

By: Kirk Boyd Chief Accounting Officer 

----
Skip to main content

Privacy Policy•Site map

# OSM Attorneys' Fees and Costs Information

Vaccine Rule 13 and Section X of the Guidelines for Practice Under the National Vaccine Injury Compensation Program ("Guidelines") address important aspects of applications for attorneys' fees and costs in the Vaccine Program. Additionally, the information at the links below is intended to assist counsel in filing a complete attorneys' fees and costs application:

1) A fees motion checklist designed to lay out all the necessary documentation counsel must submit to support the request for attorneys' fees and costs; and

2) A brief summarization of frequently arising issues in the body of case law on attorneys' fees and costs in the Vaccine Program.

Counsel should carefully review these provisions. Failure to submit a fees application without all the necessary items may result in a delay in adjudication of the motion.

Howard T. Markey National Courts Building • 717 Madison Place, NW, Washington, DC 20439 • 202-357-6400
**EXHIBIT 99.2**

 

**CERTIFICATIONOF CHIEF FINANCIAL OFFICER**

 

Theundersigned Chief Financial Officer of Medicsight, Inc. (the “Company”)certifies that:

 

1.  Thisstatement is being filed pursuant to 18 U.S.C. 1350.

 

2.  Thisstatement accompanies the Company’s Quarterly Report on Form 10-Q for thequarterly period ended March 31, 2003 (the “Quarterly Report”), which containsunaudited financial statements of the Company for such fiscal quarter.

 

3.  TheQuarterly Report complies fully with the requirements of Sections 13(a) or15(d) of the Securities Exchange Act of 1934, as amended, and the informationcontained in the Quarterly Report fairly present, in all material respects, thefinancial condition and results of operations of the Company.

 

Thisstatements has been signed by the following person in the capacity indicated onMay 14, 2003.

 

 
| By:    |   | /s/ PAUL GOTHARD         |
|--------|--------|--------------------------|
|   |   | Paul Gothard             |
|   |   | Chief  Financial Officer |

 

----